Jonathan Bowen dot Boston

Tag: MGB Chief Investment Officer

  • THE MGB Master Control Program

    THE MGB Master Control Program

    The Machinery Changes

    The machinery of money and power keeps changing; its oldest temptations endure. The Bible, the Code of Hammurabi, and TRON turn moral teaching, rule, and story into three expressions of the same natural law: the person who controls another’s money must not convert it into personal power. Ancient Babylon and the digital Grid converge whenever control begins serving the controller.

    The Bible presents the conflict as a choice between masters. Hammurabi turns entrusted property into a public rule that forces the controller to account for his actions. TRON carries the conflict into a futuristic computer world, where a control system protects Ed Dillinger and destroys the program sent to expose his theft.

    ERISA carries those durable restraints into modern fiduciary law: a duty of loyalty, a prohibition on self-dealing, and a standard of prudence. MGB’s Master Trust operates through newer machinery; the governing ideas have not changed. Who is served when retirement money, institutional power, and MGB’s own investment interests meet?

    God and Money

    The Bible begins at the moral problem beneath fiduciary duty; divided loyalty is not a management challenge to be balanced but an impossibility to be rejected.

    “No one can serve two masters, for either he will hate the one and love the other, or he will be devoted to the one and despise the other. You cannot serve God and money.”
    — Matthew 6:24 ESV1

    Matthew and Luke describe a person and money; neither passage describes two people or two pools of money. ERISA retains that human premise. A fiduciary must use plan assets “solely in the interest of the participants and beneficiaries” and “for the exclusive purpose” of providing benefits and paying reasonable plan expenses.2

    “No one can serve two masters. Either you will hate the one and love the other, or you will be devoted to the one and despise the other. You cannot serve both God and money.”
    — Luke 16:13 NIV3

    MGB’s 2022 Summary Plan Description says professional investment managers assisting the Master Trust are selected by MGB’s Board of Directors, and it identifies the Plan Trustees by office: the Chief Financial Officer, Chief Investment Officer, and Chief Human Resources Officer. The FY2025 audit assigns oversight of the Trust’s pension assets and MGB’s central investment pools to “the Investment Committee of the Company’s Board of Directors,” shortened here to the Board Investment Committee (BIC). MGB identifies the decision structure and the trustees’ offices in those sources but leaves the BIC’s charter, membership, conflict disclosures, recusal records, or votes outside the public record; that missing nameplate hangs above the people MGB says oversee pension assets and manager selection.4

    MGB’s public record puts three current directors beside three cited outside investment-platform roles and three FY2025 Master Trust holdings.

    Current MGB DirectorCited Outside Investment Platform RoleFY2025 Reported Master Trust Holding
    Robert G. AtchinsonAdage managing member — February 2024 SEC filing$797.2 million
    Nitin NohriaThrive Capital partner and executive chairman — January 2022 announcement$74.6 million
    Carol A. ValloneBerkshire Partners Industry Advisor — webpage accessed July 21st, 2026$9.8 million

    Robert G. Atchinson is a current MGB director, and a February 2024 SEC filing identifies him as a managing member in Adage’s manager and general-partner control chain. The FY2025 Master Trust reports $797.2 million in Adage Capital Partners; its Schedule C identifies Adage under an eligible-indirect-compensation reporting option that required the Trust to receive written disclosures stating the compensation amount, estimate, or formula. At $797.2 million, the question is concrete: who selected, approved, or monitored Adage, and did that person serve plan participants and beneficiaries or the money?5

    Nitin Nohria is a current MGB director, and a January 2022 Thrive Capital announcement says he joined the firm as partner and executive chairman. The FY2025 Master Trust reports $74.6 million across eight Thrive positions; its Schedule C identifies Thrive Capital Management under the same eligible-indirect-compensation reporting option, which required the Trust to receive the underlying written compensation disclosures. At $74.6 million, the question is concrete: who selected, approved, or monitored Thrive, and did that person serve plan participants and beneficiaries or the money?6

    Carol A. Vallone is a current MGB director, and Berkshire’s cited webpage identifies her as an Industry Advisor whose role may include deal origination, due diligence, and investment deliberation. The FY2025 Master Trust reports $9.8 million across four Berkshire positions. At $9.8 million, the question is concrete: who selected, approved, or monitored Berkshire, and did that person serve plan participants and beneficiaries or the money?7

    MGB’s cited records do not identify whether Atchinson, Nohria, or Vallone sat on the BIC or took part in a decision involving these platforms; that missing record establishes the demand: identify the BIC, produce the approval records, conflict disclosures, eligible-indirect-compensation disclosures, investment-platform selection records, and recusal records, and show whose interest governed the $881.6 million. Atchinson, Nohria, and Vallone make the stakes concrete: three current MGB directors, three cited outside roles, and $881.6 million in retirement-plan holdings. ERISA names only one permissible master — plan participants and beneficiaries.

    Hammurabi Demands Accounting

    Hammurabi supplies the second boundary. His law collection, engraved around 1750 BCE — that’s almost 3,800 years ago — was direct about property given to someone else for delivery.8 The money has changed form across four millennia; the duty to account has not.

    “If a man … gave a man silver, gold … or small possessions, and had him deliver them on consignment … but kept it himself … that man will give the owner … up to five times anything that was given to him.”
    — Hammurabi § 1129, c. 1750 BCE

    ERISA states the modern boundary in blunt language: a fiduciary shall not “deal with the assets of the plan in his own interest or for his own account.”10 Hammurabi’s rule and ERISA’s prohibition meet at one demand. The entrusted property cannot become the controller’s own instrument.

    Magenta Therapeutics, Revolution Medicines, and Tango Therapeutics carry Hammurabi’s accounting demand into MGB’s public record. H35M identifies the Master Trust’s Partners Distributed Stock attachment to Form 5500. SEC-filed agreements pair EP and PIA vehicles; the public records identify the Master Trust as the EP’s managing member and place the PIA vehicle beside the EP vehicle as another MGB investment lane.

    CompanyERISA Side Vehicle Named in the Public RecordOther MGB Investment Records Named in the Public RecordMaster Trust Form 5500 Record
    Magenta TherapeuticsPortland Magenta EP, LLC, with the Master Trust as managing memberPortland Magenta PIA, LLC
    Partners Innovation Fund, LLC
    Partners Innovation Fund II, L.P.
    MGB Ventures IPO portfolio    		96,244 shares in H35M through FY202011
    Revolution MedicinesPortland RevMed EP, LLC, with the Master Trust as managing member in a June 2019 agreementPortland RevMed PIA, LLC
    MGB Form 13F reports 344,091 aggregate shares    		$720,000 in Portland RevMed ER LLC at FY2018; 989,672.8 preferred shares at FY2019; 152,186 common shares in H35M from FY2020 through FY202512
    Tango TherapeuticsPortland Investment—EP, LLC, identified as Master Trust-managed in an SEC-filed Fulcrum agreementPortland Investment—PIA, LLC
    MGB Form 13F reports 354,192 aggregate shares    		159,386 shares in H35M at FY202513

    Magenta Therapeutics creates the first record; its April 2018 investor-rights agreement identifies Portland Magenta EP, LLC beside Portland Magenta PIA, LLC, Partners Innovation Fund, LLC, and Partners Innovation Fund II, L.P., with the Master Trust signing as the EP’s managing member. MGB Ventures separately lists Magenta in its IPO portfolio, and the Master Trust reported 96,244 Magenta shares in H35M through FY2020. MGB’s answer requires the account-treatment, allocation, approval, conflict, exit, pricing, and valuation records that explain how each investment lane entered, moved through, or left the same company.

    Revolution Medicines creates the second record; its June 2019 agreement identifies Portland RevMed EP, LLC, signed through the Master Trust as managing member, beside Portland RevMed PIA, LLC and Third Rock Ventures II, III, and IV. The Master Trust’s FY2018 filing separately reports a $720,000 interest in Portland RevMed ER LLC; its later filings separately report 989,672.8 Series B preferred shares in FY2019 and 152,186 common shares in H35M from FY2020 through FY2025, while MGB’s March 2026 Form 13F separately reports 344,091 Revolution shares. MGB’s answer requires the allocation, approval, conflict, conversion, cost-basis, disposition, distribution, private-investment, and valuation records that explain whether and how the positions are connected.

    Tango Therapeutics creates the third record; its 2021 agreement names Portland Investment—EP, LLC and Portland Investment—PIA, LLC, both signed by David B. Weden III. Fulcrum Therapeutics’ August 2018 agreement, filed with the SEC in June 2019, identifies the Master Trust as managing member of Portland Investment—EP, LLC, and Tango’s 2022 prospectus attributes 159,386 shares to the EP and 194,806 shares to the PIA, while MGB’s March 2026 Form 13F reports their exact 354,192-share sum without allocating that aggregate between the two entities. MGB’s FY2025 Master Trust attachment reports the exact 159,386 EP shares in H35M; that cross-date numerical match places the account-treatment, allocation, approval, conflict, disposition, pricing, and valuation records at the center of an ERISA review.

    Three company records reveal one recurring architecture: an ERISA-side company vehicle, another MGB investment lane, and public records that place both lanes inside the same company across different dates; that architecture turns an ERISA review into a records demand. MGB can answer only by showing the allocation policies, approval memoranda, capital accounts, conflict disclosures, distribution notices, exit records, pricing records, recusal records, and valuation memoranda. Hammurabi would recognize the test; the controller cannot convert entrusted property into a private instrument.

    Behind Master Control

    TRON supplies the third image through Disney’s own synopsis. Ed Dillinger steals Kevin Flynn’s programs and claims them as his own “in an effort to boost his own career.” Flynn searches for evidence while Dillinger’s Master Control Program tries to stop him and Alan Bradley’s security program Tron joins the effort to destroy the MCP.14

    ERISA supplies the rule: a plan fiduciary must act with “care, skill, prudence, and diligence”; prudence is a process that must withstand scrutiny, and a control system cannot prove integrity without independent review.15

    MGB’s Board Investment Committee occupies the real control room. MGB’s FY2025 audit assigns the BIC oversight of both the Master Trust’s pension assets and MGB’s central investment pools. MGB’s cited records name the room but leave its occupants unidentified.

    MGB’s FY2025 Form 5500 makes the stakes tangible: $10.5 billion of the Master Trust’s $11.5 billion in itemized current value — 91.7% — appeared in three reported lines: partnership and joint venture interests, common and collective trusts, and registered investment companies; that structure puts manager selection, conflict review, fee review, valuation, and monitoring at the center of fiduciary work. MGB’s FY2025 audit says the Master Trust’s managers may operate from a single sub-asset class to broad mandates, with restrictions ranging from long-only to unconstrained; it also says the Trust’s objective considers “ability and willingness to incur market risk.” The scale of the Master Trust turns manager selection and monitoring into the central prudence question.16

    TRON’s danger is not size alone; the danger is concentrated power without an independent check strong enough to keep control from becoming its own purpose.

    ERISA prudence demands a process that can show its work: manager screening, conflict review, valuation, approval, and monitoring through disposition whenever MGB’s own interests enter the room.

    MGB’s audited numbers expose the scale inside that control room.

    As of September 30th, 2025, MGB reported $11.6 billion in defined-benefit plan assets inside the Master Trust. The 91.7% calculation uses the Form 5500’s separate $11.5 billion itemized-current-value denominator. MGB’s FY2025 audited statements supply every figure in the comparison table below, which displays dollar values to one decimal place and calculates every ratio from the statements’ unrounded figures; the overlap between the $18.3 billion central-pool measure and the broader $19.4 billion investment base prevents a valid combined total.

    FY2025 Reported MeasureReported AmountMaster Trust ComparisonWhy $11.6 Billion Matters
    Defined-benefit plan assets in the Master Trust$11.6 billionReference amountEvery comparison begins with $11.6 billion of retirement money.
    Defined-benefit obligations$9.3 billion124.7%; $2.3 billion above the reported obligationMGB reports plan assets that exceed the benefit obligation by $2.3 billion under the audited GAAP measurement.
    MGB’s three central investment pools$18.3 billion63.5% of the pools; the pools are 1.6 times the TrustThe Trust is nearly two-thirds as large as MGB’s central investment pools.
    Reported non-pension investment line items, including separately managed and limited-as-to-use assets$19.4 billion59.8%The Trust equals nearly three-fifths of the broader investment base reported on MGB’s balance sheet.
    Annual operating revenue$22.8 billion50.8%The retirement pool equals more than half of one year’s operating revenue; this ratio measures scale, not liquidity or funding.

    At $11.6 billion, the Master Trust stands $2.3 billion above MGB’s defined-benefit obligations and equals 124.7% of those obligations, 63.5% of its three central investment pools, 59.8% of its reported non-pension investment base, and 50.8% of its annual operating revenue; that scale removes any excuse for MGB stakeholders, the Massachusetts Nurses Association (MNA), or the Employee Benefits Security Administration (EBSA) to treat the Trust as background scenery.

    Magenta Therapeutics turns the control question into the first record: a Master Trust-managed vehicle, MGB’s pooled-investment vehicle, and two Partners Innovation Funds appear inside Magenta’s capital structure. Revolution Medicines supplies the second record: separate Master Trust filings report a $720,000 interest in Portland RevMed ER LLC and 152,186 common shares in Revolution Medicines, while MGB reports 344,091 Revolution shares in aggregate. Tango Therapeutics supplies the third record: a 2022 prospectus attributes 159,386 shares to the EP and 194,806 shares to the PIA, while MGB’s 2026 Form 13F reports the same 354,192-share aggregate without allocating it between those entities. MGB’s own audit places the Master Trust and its central investment pools under the same BIC. When the Master Trust meets a company that MGB Ventures calls a portfolio company, whose interest rules the decision?

    Only One Master

    MGB can answer the ERISA question only through the allocation, approval, conflict, distribution, fee, recusal, and valuation records; those records will show whether the Master Trust’s process served participants and beneficiaries alone.

    The Bible resolves divided loyalty by refusing the premise of two masters. Hammurabi resolves entrusted property by forcing the controller to account. TRON resolves concentrated control by giving the system an independent monitor. ERISA binds all three ideas through a duty of loyalty, a prohibition on self-dealing, and a standard of prudence that must withstand scrutiny. ERISA subjects a person to fiduciary duties to the extent that person exercised discretionary authority or control over management of the Master Trust or any authority or control over management or disposition of its assets; the Trust’s $11.6 billion scale makes the demand from disciples of Jesus, subjects of Hammurabi, and Users of the Grid impossible to dismiss.17

    The machinery of money and power will keep changing; fiduciary duty exists because the boundaries cannot change with the machinery. ERISA demands one exclusive allegiance from every fiduciary who exercises discretionary authority over MGB’s Master Trust or control over its assets — allegiance to plan participants and beneficiaries. MGB controls the records; the burden belongs to MGB.

    Source Notes

    1. Matthew 6:24 ESV. ↩︎
    2. 29 U.S.C. § 1104(a)(1)(A). ↩︎
    3. Luke 16:13 NIV. ↩︎
    4. MGB governance and investment oversight: Consolidated Cash Balance Program of Mass General Brigham and Member Organizations — Summary Plan Description, effective January 1st, 2022; and Mass General Brigham — Consolidated Audited Financial Statements, FY2025 and FY2024. ↩︎
    5. Robert G. Atchinson record: Mass General Brigham — Leadership and Governance, accessed July 21st, 2026; SEC Schedule 13G/A — Adage Capital Control Chain, February 7th, 2024; MGB ERISA Master Trust — Form 5500, plan year ended September 30th, 2025 (Schedule H attachment and Schedule C); and U.S. Department of Labor — 2025 Instructions for Form 5500 (Schedule C eligible-indirect-compensation alternative reporting option and required written disclosures). ↩︎
    6. Nitin Nohria record: Mass General Brigham — Leadership and Governance, accessed July 21st, 2026; Thrive Capital — Nitin Nohria Appointment, January 14th, 2022; MGB ERISA Master Trust — Form 5500, plan year ended September 30th, 2025 (Schedule H attachment and Schedule C); and U.S. Department of Labor — 2025 Instructions for Form 5500 (Schedule C eligible-indirect-compensation alternative reporting option and required written disclosures). ↩︎
    7. Carol A. Vallone record: Mass General Brigham — Leadership and Governance, accessed July 21st, 2026; Berkshire Partners — Carol Vallone, accessed July 21st, 2026; and MGB ERISA Master Trust — Form 5500, plan year ended September 30th, 2025 (Schedule H attachment and Schedule C). ↩︎
    8. The Code of Hammurabi — Musée du Louvre. ↩︎
    9. Hammurabi § 112 — eHammurabi. ↩︎
    10. 29 U.S.C. § 1106(b)(1). ↩︎
    11. Magenta Therapeutics record: Second Amended and Restated Investors’ Rights Agreement, April 2nd, 2018; Mass General Brigham Ventures — Investment Portfolio; and U.S. Department of Labor EFAST2 filing receipts for FY2018, FY2019, and FY2020 (EIN 04-3294527, plan 004; Schedule H attachments). ↩︎
    12. Revolution Medicines record: Amended and Restated Investors’ Rights Agreement, June 5th, 2019; U.S. Department of Labor EFAST2 filing receipts for FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, and FY2025 (FY2018 reports Portland RevMed ER LLC; later filings separately report the cited Revolution positions); and MGB Form 13F Information Table, March 31st, 2026. ↩︎
    13. Tango Therapeutics record: Registration and Stockholder Rights Agreement, August 10th, 2021; Post-Effective Amendment No. 1, filed September 2nd, 2022; Fulcrum Therapeutics — Amended and Restated Investors’ Rights Agreement, August 24th, 2018, filed June 21st, 2019; MGB Form 13F Information Table, March 31st, 2026; and MGB ERISA Master Trust Form 5500, FY2025. ↩︎
    14. TRON plot, futurism, and terminology: TRON Premieres — D23; Celebrate Over 40 Years of TRON Downloading Us into the World of Computers — D23; and Solve a Mystery in an All-New Grid—TRON: Identity Launches Today! — D23. ↩︎
    15. 29 U.S.C. § 1104(a)(1)(B); 29 C.F.R. § 2550.404a-1 — Investment Duties; and Tibble v. Edison International, 575 U.S. 523 (2015). ↩︎
    16. MGB Master Trust scale and investment-policy record: MGB ERISA Master Trust — Form 5500, plan year ended September 30th, 2025 (Schedule H line 4i asset-category summary, page 126; amounts rounded to the nearest dollar: $9,162,207,557 + $666,947,438 + $675,012,223 = $10,504,167,218; divided by $11,453,534,771 = 91.7%); and Mass General Brigham — Consolidated Audited Financial Statements, FY2025 and FY2024 (FY2025 reported amounts are in thousands; body and table dollar values are displayed to one decimal place. The four non-pension investment line items total $19,369,907: $4,660,478 + $3,364,140 + $7,404,116 + $3,941,173. Calculations from reported amounts: $11,586,293 ÷ $18,258,464 = 63.5%; $18,258,464 ÷ $11,586,293 = 1.6; $11,586,293 ÷ $19,369,907 = 59.8%; $11,586,293 ÷ $9,292,256 = 124.7%; $11,586,293 − $9,292,256 = $2,294,037; and $11,586,293 ÷ $22,807,769 = 50.8%. MGB says investments are either invested in the Pools or separately managed; the overlap between the $18.3 billion Pools measure and the $19.4 billion balance-sheet investment base prevents a valid combined total. The operating-revenue ratio compares a September 30th asset balance with full-year revenue and measures scale, not liquidity or funding). ↩︎
    17. 29 U.S.C. § 1002(21)(A). ↩︎